MedPath

EFFECTS OF TREATMENT WITH L-ARGININE ASSOCIATED TO N-ACETILCYSTEINE IN PATIENTS WITH CORONARY ISCHEMIC CARDIOPATHY EVALUATED WITH MYOCARDIAL SPECT (TC99) WITH EXERCISE

Conditions
TO IMPROVE CORONARY PERFUSION INCREASING THE PRODUCTION OF NITRIC OXIDE IN CORONAROPATHIC DIABETIC SUBJECTS BY MEANS OF ARGININE AND ACETYLCYSTEINE ADMINISTRATION
MedDRA version: 6.1Level: PTClassification code 10061815
Registration Number
EUCTR2005-002072-15-IT
Lead Sponsor
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: ;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath